uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 19, 2019

FDA Calls Promotion of Nyloxin Homeopathic Products for Pain a "Health Fraud Scam"

On March 11, 2019, the FDA issued a warning letter to Nutra Pharma Corp. following a review of the company's website ( and social media sites found that the company was making drug claims about its homeopathic products promoted for arthritis and cancer pain.

The main ingredient in Nyloxin is listed as "Asian Cobra Venom 4X" and it is sold on the company's website in various forms, including oral sprays, and topical roll-ons and gels. The products were promoted on the company's website and social media sites with statements such as "[C]obra venom saw its primary use in the treatment of cancer and arthritis. Reportedly the venom was used to treat liver cancer, lung cancer, esophageal cancer, skin cancer, and leukemia," and "Nyloxin is a new product primarily aimed at treating moderate to severe chronic pain." The products were also promoted for conditions such as asthma and Parkinson's disease, and as an alternative to opioid pain medications and for heroin dependence.

In a news release about the warning, FDA Commissioner Scott Gottlieb described the company as "preying on patients who may be seeking alternative treatments for chronic pain, cancers, arthritis and autoimmune and neurological disorders," and said that "Health fraud scams like these are inexcusable."

Homeopathy has been in use since the 1700s and is based on the philosophy that diluted substances have the ability to stimulate the body to heal itself. For example, the homeopathic "Law of Similars" states that a substance that produces a certain set of symptoms in a healthy person has the power to cure a sick person manifesting those same symptoms -- although usually the substance is given in minute quantities. 

However, in 2017 the European Academies' Science Advisory Council (EASAC) concluded there was a lack of evidence that homeopathic products are effective, and raised concerns about quality control. In 2015 in the U.S. the FTC released a statement, which read, in part, "for the majority of over-the-counter homeopathic drugs the case for efficacy is based solely on traditional homeopathic theories and there are no valid studies using current scientific methods showing the product's efficacy."

See related Warnings:

Homeopathic Oral Sprays Recalled Due to Possible Bacterial Contamination

King Bio Homeopathic Product Recall Expanded

Thirty-Two Children's Homeopathic Products Recalled

Contaminated Homeopathic Products Recalled

Hyland's Baby Teething Tablets and Nighttime Teething Tablets Recalled

FTC Announces New Enforcement Policy on Homeopathic Drug Claims

Homeopathic Teething Drops, Nausea Drops, Silver-Zinc Throat Spray & More Recalled

To read the complete recall notice, use the link below.